Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kinetics of Pathogen Reduced Red Blood Cell Clearance in Subjects Undergoing Red Cell Exchange for Sickle Cell Disease

NCT07155031 is registered in ClinicalTrials.gov with Cerus Corporation as lead sponsor.

NCT NCT07155031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kinetics of Pathogen Reduced Red Blood Cell Clearance in Subjects Undergoing Red Cell Exchange for Sickle Cell Disease
Lead sponsor
Cerus Corporation
Phase
Phase 2
Overall status
Withdrawn
Start date
October 15, 2025
Completion date
December 15, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease